ZIVO Bioscience (NASDAQ:ZIVO) Shares Pass Above 50 Day Moving Average – Should You Sell?

ZIVO Bioscience, Inc. (NASDAQ:ZIVO)’s stock price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $9.23 and traded as high as $9.8750. ZIVO Bioscience shares last traded at $9.8750, with a volume of 130 shares.

ZIVO Bioscience Stock Performance

The firm has a market cap of $39.28 million, a P/E ratio of -2.02 and a beta of 0.19. The stock’s 50 day simple moving average is $9.23 and its 200 day simple moving average is $12.10.

About ZIVO Bioscience

ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.

Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.